Table 2.

Within-person 3-month change in those with added low-dose oral micronised progesterone vs controls. Mean (95% CI) are reported. P-value from non-parametric ANCOVA adjusted for the corresponding measure at baseline.

Parameter	Progesterone group	Control group	P-value
PSQI
0 months	7.7 (6.3, 9.2)	8.4 (7.1, 9.8)
3 months	6.9 (5.1, 8.7)	8.0 (6.7, 9.3)	0.35
K10
0 months	24.4 (21.0, 27.8)	25.2 (22.0, 28.4)
3 months	22.5 (19.5, 25.5)	23.8 (20.7, 27.0)	0.64
Tanner stage
0 months	3.3 (3.1, 3.6)	3.3 (3.0, 3.7)
3 months	3.5 (3.2, 3.7)	3.6 (3.3, 3.9)	0.42

K10, Kessler psychological distress scale; PSQI, Pittsburgh Sleep Quality Index.